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Abstract
 
The pre-B cell receptor consists of immunoglobulin (Ig) 
 
m
 
 heavy chains and surrogate light
chain, i.e., the VpreB and 
 
l
 
5 proteins. To analyze the role of the two VpreB proteins, mice
 
lacking the 
 
VpreB1
 
 and 
 
VpreB2
 
 genes were generated. 
 
VpreB1
 
2
 
/
 
2
 
VpreB2
 
2
 
/
 
2
 
 mice were im-
paired in their B cell development at the transition from pre-BI to large pre-BII cells. Pre-BII
cells did not expand by proliferation, consequently 40-fold less small pre-BII and immature B
 
cells were found in bone marrow, and the generation of immature and mature conventional B cells
in spleen appeared reduced. In addition, only low numbers of B-1a cells were detected in the
peritoneum. Surprisingly, Ig heavy chain allelic exclusion was still active, apparently ruling out
a signaling role of a VpreB1/VpreB2–containing receptor in this process.
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Introduction
 
Mouse B cell development follows a sequence of cellular
stages which are characterized by selective expression of
cell surface receptors and stage-specific genes, and which
can be ordered in development by their status of rearrange-
ment in the IgH and L chain gene loci (1–6). One selective
marker of early B cell development is the surrogate light
 
(SL)
 
1
 
 chain composed of the VpreB and 
 
l
 
5 proteins (7–11).
Mice have two 
 
VpreB
 
 genes, 
 
VpreB1
 
 and 
 
VpreB2
 
, sepa-
rated by an unknown distance on chromosome 16 (8). The
two genes show 97% identity at the nucleotide and amino
acid level, giving rise to a difference of four amino acids in
the protein. The 
 
VpreB1
 
 gene is expressed in all cells that
 
express 
 
l
 
5, whereas 
 
VpreB2
 
 RNA is detected in 
 
z
 
30% of
these same cells as determined by single cell reverse tran-
scription (RT)-PCR (12). Both 
 
VpreB
 
 gene products are
functional and can form an SL chain with 
 
l
 
5 (12, 13).
 
The earliest identifiable B-lineage progenitor already
transcribes, and probably also expresses as protein, the SL
 
chain (14, 15). The cell population is in the process of
 
DJ
 
H
 
 rearrangements, and is phenotypically characterized
 
as B220
 
1
 
CD19
 
2
 
c-kit
 
1
 
flk-2
 
1
 
. B220
 
1
 
CD19
 
1
 
c-kit
 
1
 
flk-2
 
2
 
pre-BI cells follow, which have both 
 
IgH
 
 chain alleles DJ
 
H
 
rearranged and express the SL chain as protein associated
with gp130 (13, 16). The function of this protein complex
is unknown, especially because pre-BI cells are generated in
 
l
 
5-deficient mice, even in elevated numbers (17).
 
At the transition of pre-BI to pre-BII cells, V
 
 
 
to DJ
 
H
 
 rear-
rangements are initiated. Whenever they occur in-frame, a
 
m
 
H chain can be produced which is then probed for its ca-
pacity to associate with SL chain and form a pre-B cell re-
ceptor (pre-BCR) on the cell surface (18, 19). The pre-
BCR expressing pre-BII cells are stimulated to enter the cell
cycle and become large pre-BII cells. They downregulate
the expression of c-kit, SL-chain, and of the rearrangement
machinery, i.e., recombination activating gene (
 
RAG
 
)
 
-1
 
,
 
RAG-2
 
, and terminal deoxynucleotidyl transferase (TdT),
and upregulate CD25 expression (2, 20). Allelic exclusion is
established at the IgH chain alleles, either because the first
allele was nonproductively VDJ
 
H
 
 rearranged, or because the
cell is inhibited from recombining the second DJ
 
H
 
 rear-
ranged allele. The latter is thought to be effected both by
the immediate downregulation of the rearrangement ma-
chinery, as well as by a closing of the DJ
 
H
 
 rearranged allele,
both signaled by the deposition of pre-BCR in the surface
membrane of large pre-BII cells (21–24). Hence, cells with
productive VDJ
 
H
 
 rearrangements resulting in a 
 
m
 
H chain
which is incapable of forming a pre-BCR are not allelically
excluded in wild-type B-lineage cells (25). Large pre-BII
cells proliferate for two to five divisions, then come to rest
as small pre-BII cells which continue to express CD25 (26).
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stem; RAG, recombination activating gene; RT, reverse transcription;
SL, surrogate light. 
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/
 
2
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2
 
/
 
2
 
 Mice
 
At the transition of large to small pre-BII cells, rearrange-
ments at the 
 
IgL
 
 chain gene loci are initiated. Whenever
they are productive and lead to the synthesis of a 
 
m
 
H chain
pairing IgL chain, immature sIgM
 
1
 
sIgD
 
2
 
AA4.1
 
1
 
 B cells are
formed which become subject to selection by autoanti-
gen (21). Negative selection deletes autoreactive B cells,
whereas B-1 cells may be generated by positive selection
(27). Finally, mature, conventional B cells appear to be gen-
erated in two steps, first by migration of immature cells
from bone marrow to spleen, second by maturation of im-
mature to mature, sIgM
 
1
 
sIgD
 
1
 
AA4.1
 
2
 
 cells in spleen (28).
SL chain becomes undetectable in small pre-BII cells, as
large pre-BII cells loose pre-BCR surface expression. This
appears to confine all functional influences of the SL chain
to cells before the small pre-BII cell stage.
In mice lacking the transmembrane portion of 
 
m
 
H chain
(
 
m
 
mT) the development of B cells appears impeded at the
transition from the pre-BI into large pre-BII stage, so that
the cells can V to DJ
 
H
 
 rearrange the 
 
IgH
 
 locus but cannot
express a membrane-bound pre-BCR and are unable to
enter the cell cycle (29). In the 
 
m
 
mT mice, the 
 
m
 
H chains
are allelically included, i.e., cells expressing two 
 
m
 
H chain
proteins from the two IgH chain alleles are found in 9% of
all cells at that stage (30). Mice lacking 
 
l
 
5 (
 
l
 
5
 
2
 
/
 
2
 
) are also
impaired in B cell development at the transition from the
pre-BI into the large pre-BII stage, again evident in a lack
of proliferation of pre-BII cells (17, 31). However, 
 
l
 
5 defi-
ciency does not result in a complete block in B cell devel-
opment, as low numbers of small pre-BII, immature, and
mature B lymphocytes are produced. Surprisingly, IgH al-
lelic exclusion is functioning in 
 
l
 
5
 
2
 
/
 
2
 
 mice (25). One hy-
pothesis to explain this finding is that a pre-BII cell can
make a modified pre-BCR consisting of 
 
m
 
H chain and the
VpreB polypeptide(s), unable to signal proliferation, but
able to signal allelic exclusion.
We have recently described the analysis of mice lacking
the 
 
VpreB1 
 
(
 
VpreB1
 
2
 
/
 
2
 
) gene (32). These mice use a SL
chain composed of VpreB2 and 
 
l
 
5 which appears to be
sufficient, although not as efficient as VpreB1 (or VpreB1
plus VpreB2) to form a functional SL chain. A partial block
at the transition from pre-BI to large pre-BII cells was
found, possibly due to lowered efficiency of this SL chain
in its capacity to pair with different 
 
m
 
H chains. However,
the cells that reach the large pre-BII stage are expanded in a
normal fashion.
Here we have established mice lacking both 
 
VpreB1
 
 and
 
VpreB2
 
 in the germline (
 
VpreB1
 
2
 
/
 
2
 
VpreB2
 
2
 
/
 
2
 
) in order to
analyze the combined effects of these two genes on B cell
development and IgH allelic exclusion.
 
Materials and Methods
 
Targeting Vectors.
 
Conventional DNA techniques were used
to construct the targeting vectors (33). The 
 
VpreB1
 
 targeting vec-
tor has been described previously (32). In brief, the 
 
VpreB1
 
 vector
contained 5.3 kb of genomic sequence from the 
 
VpreB1
 
 locus and
the 
 
neomycin
 
 resistance gene. In the 
 
VpreB2
 
 targeting vector (129
 
DNA), the entire 
 
VpreB2
 
 coding sequence was replaced by the
1.9-kb 
 
hygromycin
 
 resistance gene. The final 
 
VpreB2
 
 targeting vec-
tor comprised from 5
 
9
 
 to 3
 
9
 
: 1.2 kb of 5
 
9
 
 
 
VpreB2
 
 genomic se-
quence, the hygromycin resistance gene (opposite transcriptional
orientation), and 7.2 kb of 39  VpreB2 genomic sequence (se-
quence data are available from GenBank/EMBL/DDBJ under
accession no. AC005817). Restriction enzyme sites are indicated
in Fig. 1 A (SalI site originates from the vector). Homologous in-
tegration introduced two new EcoRI restriction enzyme sites.
ES Cells and Transfections. Embryonic stem (ES) cells were
grown on irradiated embryonic fibroblasts (resistant to G418 and
hygromycin) in IMDM (Life Technologies) supplemented with
MEM nonessential amino acids, 5 3 1025 M 2-mercaptoethanol,
penicillin, and streptomycin, 0.1% LIF, and 15% FCS (Boeh-
ringer). The VpreB1-targeted Y2 clone (32) was used as the recip-
ient of the VpreB2 targeting vector. Resistant clones (150 mg/ml
hygromycin) were picked 7–9 d after transfection, expanded, and
frozen, and genomic DNA was prepared.
Screening of Targeted Clones. ES clones were screened by PCR
using primers no. 1 and no. 2 (Fig. 1 A). Homologous recombi-
nation results in a product of 1.8 kb. Primer sequences: VpreB2
no. 1, 59-ATGCCCACTTGTCTGCCTCTATC-39;  hygromy-
cin: no. 2, 59-ACCGATGGCTGTGTAGAAGTACT-39. Con-
ditions: 40 cycles of 948C, 30 s; 608C, 30 s; 728C, 2.5 min. A to-
tal of 585 hygromycin-resistant clones were analyzed and 6 clones
were targeted in the VpreB2 locus. Positive ES clones were also
analyzed by Southern blotting. Several probes located outside the
targeting vector were tested but on account of the high degree of
repetitive sequences in the VpreB2 region these did not hybridize
specifically. One probe (Fig. 1 A) was better than the others; it
also gave rise to a high background, but did confirm proper tar-
geting of the VpreB2 locus (data not shown).
Establishing Mice Targeted in Both the VpreB1 and VpreB2 Loci.
The murine VpreB1 and VpreB2 genes are both located on chro-
mosome 16 at an unknown distance from each other (8). As it
was not possible to determine if the VpreB2 locus had been tar-
geted on the same chromosome as the VpreB1-targeted locus, five
ES clones were injected into blastocysts, chimeric mice estab-
lished and bred with C57BL/6 females. The agouti offspring (all
five clones gave rise to germ line transmission) were screened for
recombination at the VpreB1 and VpreB2 loci. Targeting on the
same chromosome gives rise to 50% of the pups being positive for
both targeting events (ES94 and ES163), whereas targeting on
separate chromosomes gives rise to 50% of the pups being posi-
tive for the VpreB1 and 50% for the VpreB2 event (ES47, ES65,
and ES223). VpreB11/2VpreB21/2 heterozygous mice from
ES163 and ES94 were then inter-crossed to establish VpreB12/2
VpreB22/2 mice. The mice have been bred and investigated
under proper Project Licenses (80/1143, 1263) approved by the
Home Office, UK.
Screening of VpreB1/VpreB2-targeted Mice. After establishing
the ES94 and ES163 lines, offspring were screened by PCR. For
the VpreB1 locus, primer nos. 3, 4, and 5 were used (32). For the
VpreB2 locus, two separate reactions were performed using
primer nos. 6 and 7, primer nos. 8 and 9 (Fig. 1): VpreB1: (no. 3)
59-TGCTCATGCTGCTGGCCTAT-39;  VpreB1: (no. 4) 59-
CTCCGGAGCCCCACGGCA-39; Neomycin: (no. 5) 59-TTG-
GCTACCCGTGATATTGCTGA-39; VpreB2: (no. 6) 59-CT-
CATGCTGCTGGCCCAC-39;  VpreB2: (no. 7) 59-TCGTG-
GCTCCGGAGCCCCACAGCG-39;  hygromycin: (no. 8) 59-
GGGTAAATAGCTGCGCCGATGG-39;  hygromycin: (no. 9)
59-GCCGCAGCGATCGCATCCATGG-39. Conditions: VpreB1,
30 cycles of 948C, 20 s; 55–608C, 20 s; 728C, 30 s; VpreB2, 4 min437 Mundt et al.
at 948C, then 30 cycles of 948C, 30 s; 608C, 20 s; 728C, 15 s. Hy-
gromycin: same conditions as VpreB2.
RT-PCR Analysis. Total RNA was prepared from z107 cells
using RNAzol (Tel-Test Inc.) followed by cDNA reaction using
random primers (Life Technologies). cDNAs were analyzed by
PCR using primers specific for HGPRT, l5, VpreB1 (nos. 3 and
4), and VpreB2 (nos. 6 and 7) as described previously (12).
Analysis of VpreB and l5 Protein. Bone marrow cells from
young mice were cultured on irradiated stromal cells (S17) in the
presence of IL-7 (10% supernatant) in IMDM supplemented with
5 3 1025 M 2-mercaptoethanol, antibiotics, and 10% FCS.
Pre-BI cells, which grow out after a week in culture (34), were
analyzed on a FACSCalibur™ (Becton Dickinson) using mAbs
VP245 recognizing VpreB1 and VpreB2, and LM34 recognizing
l5 (12, 13).
FACS® Analysis of Lymphoid Organs. Bone marrow cell sus-
pensions were prepared by flushing out femurs using HBSS (Life
Technologies) supplemented with 10 mM Hepes and 3% FCS.
Spleen and thymus cell suspensions were prepared using conven-
tional techniques. Peritoneal cells were prepared by lavage of the
peritoneal cavity with 3–5 ml HBSS supplemented as above.
Cells were stained in HBSS (supplemented as above) with either
two or three mAbs in combination with propidium iodide (0.25
mg/ml PI, analyzed in FL3) to exclude dead cells and then ana-
lyzed on a FACSCalibur™ (Becton Dickinson). The following
mAbs were used: FITC- and allophycocyanin (APC)-labeled
anti-B220/CD45R (clone RA3-6B2); biotin- and FITC-labeled
anti-CD19 (clone 1D3); biotin- and PE-labeled anti–c-kit/
CD117 (clone ACK 45); biotin-labeled anti-CD43 (clone S7);
biotin-labeled anti-CD25 (clone 7D4); biotin-labeled anti-IgM
(clone R6-60.2); PE-labeled anti-IgMa (clone DS-1); FITC-
labeled anti-IgMb (clone AF6-78); FITC-labeled anti-CD4
(clone RM4-5); biotin-labeled anti-CD8a (clone 53-6.7); bi-
otin-labeled anti-CD5 (clone 53-7.3); biotin-labeled anti-Igk
(clone R5-240); and FITC-labeled anti-Igl (clone R26-46; all
from BD PharMingen). Biotin-labeled anti-IgD (clone 1.19),
anti-l5 (clone LM34), and anti-VpreB (clone VP245) were puri-
fied and biotinylated in the laboratory. Polyclonal FITC-conju-
gated goat anti–mouse-IgM was from BD PharMingen. When
biotinylated mAbs were used, positive cells were revealed using
PE-labeled streptavidin (Southern Biotechnology Associates,
Inc.). To determine IgM allotype, cells from both femurs were
stained with APC-labeled anti-B220, biotinylated anti-IgD, and
PE-labeled anti-IgMa in the presence of 5% rat serum for 30 min.
The cells were washed twice and incubated with FITC-labeled
anti-IgMb and SA-Tricolor (Caltag) for 30 min in the presence of
5% rat serum, then washed as before. This procedure was crucial
to achieve proper staining of the cells.
Serum Titres. 5-mo-old wild-type, heterozygous, and ho-
mozygous VpreB1/VpreB2 double-mutant mice were bled and
the sera analyzed for the presence of IgM. ELISA plates were
coated with 2 mg/ml of an mAb recognizing mouse IgM (R6-
60.2; BD PharMingen). The samples were serially diluted, added
to the plates, and bound IgM was detected with a biotinylated
goat anti–mouse IgM antiserum (Sigma-Aldrich) and streptavi-
din-biotinylated horseradish peroxidase (Amersham Pharmacia
Biotech) using o-phenylene-diamine (Sigma-Aldrich) as sub-
strate. The ELISA was measured in a Multiskan MCC/340 plate
reader (Titertek) at 492 nm. The concentration of IgM was cal-
culated using purified mouse IgM (Sigma-Aldrich) as standard.
Immunizations. Wild-type, heterozygous, and homozygous
VpreB1/VpreB2 double-mutant mice, at the age of z4–5 mo,
were immunized with 100 mg alumprecipitate of either phenyl-
oxazolone coupled to OVA (Ox-OVA) or OVA, or 5 mg NP-
Ficoll. 2 wk after immunization, the mice were bled and the sera
analyzed for the presence of antigen-specific Abs (IgM, IgG).
ELISA plates were coated with either Ox-BSA, OVA, or NP-
OVA at a concentration of 10 mg/ml. Samples were serially di-
luted and added to the plates. Antigen-specific IgM was detected
with a biotinylated goat anti–mouse IgM antiserum (Sigma-
Aldrich), and IgG with a biotinylated goat anti–mouse IgG anti-
serum (Sigma-Aldrich). The detection was as described above.
Results
Establishment of VpreB12/2VpreB22/2 Mice. To ana-
lyze how the two VpreB genes, on chromosome 16 of the
mouse, influence B cell development, the two genes were
replaced by homologous integration of antibiotic resistance
genes. Earlier we have described the targeting of the
VpreB1 gene (32), which yielded the Y2 ES clone that is
neomycin resistant and heterozygous for the targeting
event. This ES clone was used as recipient for the VpreB2
targeting construct. The VpreB2 targeting vector was made
by substituting the VpreB2 coding sequences for the gene
encoding  hygromycin resistance. It included z9 kb of
VpreB2 homologous sequences (Fig. 1 A). As both VpreB
genes are located on chromosome 16, and if the targeting
of the VpreB2 construct occurs randomly and is not influ-
enced by the first integration, half of all successfully tar-
geted ES clones should have both targeting constructs
(VpreB1 and VpreB2) integrated on the same chromosome.
Out of five double VpreB1/VpreB2 targeted ES clones, two
were found to have integrated the two vectors on the same
chromosome (ES94 and ES163). The others, ES47, ES65,
and ES223, were found to be targeted for VpreB1 on one,
and for VpreB2 on the other chromosome 16.
Targeting of the VpreB2 locus was determined by PCR,
in which homologous recombination gives rise to a 1.8-kb
product (Fig. 1 A, primer nos. 1 and 2). Fig. 1 B shows that
ES94 and ES163 both gave rise to a 1.8-kb PCR product,
whereas the original E14 and the recipient Y2 cells did not.
Heterozygous and homozygous VpreB1/VpreB2  double-
mutant mice from ES94 and ES163 also produced the 1.8-
kb PCR product whereas the respective wild-type mice
did not, demonstrating that homologous recombination
had occurred at the VpreB2 locus. The targeting of the
VpreB2 locus was further confirmed by Southern blotting
(see Materials and Methods, and data not shown). Further
analysis of ES94 and ES163, using the hygromycin resistance
gene as a probe, demonstrated that ES94 carried only one
copy of the VpreB2 targeting vector, whereas ES163 had
integrated at least one more copy elsewhere in the genome
(data not shown). To determine the status of the VpreB1
locus, we used Southern blotting (32) and, as shown in Fig.
1 D, the VpreB1 locus remained intact after the second tar-
geting event. The deletion of the two VpreB genes was fur-
ther confirmed by Southern blotting using VpreB1 cDNA
as a probe (data not shown). Thus, ES94 and ES163 gave
rise to mice lacking both VpreB1 and VpreB2. As the tar-
geting of VpreB1 and VpreB2 was correct in both strains438 Impaired B Cell Development in VpreB12/2VpreB22/2 Mice
we analyzed mice derived from both ES94 and ES163
(VpreB12/2VpreB22/2).
Lack of VpreB RNA Expression in VpreB12/2VpreB22/2
Mice. After establishing that the mice were correctly tar-
geted, we investigated whether any RNA encoding VpreB
could be detected. For this purpose, we analyzed RNA
from bone marrow cells by RT-PCR using primers that
were specific for the respective VpreB gene (12). RNA en-
coding VpreB1 and VpreB2 was detected in both wild-type
and heterozygous mice, whereas there was no message
found in VpreB12/2VpreB22/2 mice, as revealed for both
ES163 and ES94 (Fig. 2 A). The l5 gene, which encodes
the other component of the SL chain, is located just down-
stream of the VpreB1 gene (Fig. 1 C). To find out if the ex-
pression of this gene had been affected by the targeting
events, expression of this gene was also analyzed. l5 RNA
was present in all samples, independent of genotype, sug-
gesting that its expression had not been altered. As a con-
trol for the RT-PCR assays, RNA representing a house
keeping gene (HGPRT) was measured and was detected in
all bone marrow samples independent of genotype. Thus,
VpreB12/2VpreB22/2 mice lacked VpreB1 and VpreB2
RNA but expressed l5 RNA at apparently normal levels.
Lack of VpreB Protein Expression. The lack of VpreB
RNA implied that there should also be a lack of VpreB
protein. To test this, we analyzed in vitro–cultured pre-BI
cells which express the SL chain on the cell surface to-
gether with a set of glycoproteins, i.e., the pro-BCR (13,
34, 35). Pre-BI cells from heterozygous ES94 mice ex-
pressed VpreB on the cell surface (Fig. 2 B), as demon-
strated by staining with an mAb (VP245) recognizing both
VpreB1 and VpreB2 (12, 13). In contrast, pre-BI cells from
VpreB12/2VpreB22/2 mice were not recognized by the
Figure 1. Homologous recombination of
VpreB1 and VpreB2. (A) VpreB2 genomic
locus before and after homologous integra-
tion. The targeting vector consists of 8.4 kb
of  VpreB2 genomic sequences and the
VpreB2 coding sequence replaced by the hy-
gromycin (hygro) resistance gene. Shown is
the location of primers used for detection of
homologous recombination (nos. 1 and 2),
giving rise to a 1.8-kb PCR product. Off-
spring were later screened by PCR with
primer nos. 6 and 7 and nos. 8 and 9, and
the expected size of the respective product
is indicated. The probe for Southern blot-
ting and expected fragments are indicated.
Restriction enzymes: R, EcoRI; H, Hind-
III; K, KpnI; S, SalI. (B) The arrow indi-
cates the 1.8-kb PCR product (primer nos.
1 and 2) upon homologous recombination
of the VpreB2 locus. E14, original nontar-
geted ES cells; Y2, VpreB1-targeted E14
cells; ES94 and ES163, VpreB2-targeted Y2
cells; ES94 and ES163 mice, mice estab-
lished from these ES clones. (C) The VpreB1 genomic locus before and after homologous integration. The VpreB1 targeting vector consisted of 5.3 kb of
VpreB1 genomic sequences and the neomycin (neo) resistance gene which replaced the VpreB1 coding sequence. Primer nos. 3, 4, and 5 were used to
screen for genotype and the expected size of the respective product is shown. The probe used for Southern blotting is indicated and expected fragments.
Restriction enzymes: R, EcoRI; X, XbaI. (D) Homologous recombination of the VpreB1 locus using the probe in C. Samples are as indicated in B, ex-
cept ES65. The asterisk (*) shows the extra band detected in ES163 ES cells and in ES163 1/2 and 2/2 mice.
Figure 2. Lack of VpreB expression in VpreB12/2VpreB22/2 pre-B
cells. (A) Total RNA from bone marrow cells of the indicated mice. RT-
PCR was performed for HGPRT, VpreB1, VpreB2, and l5. C indicates
negative control. (B) In vitro cultured pre-BI cells were stained for B220
in combination with VP245 (anti-VpreB), LM34 (anti-l5), or c-kit and
analyzed by FACS®. The histograms from the VP245, LM34, and CD117
stains are shown.439 Mundt et al.
VP245 Ab and, hence, did not express VpreB on the cell
surface. The pre-BI cultures, independent of genotype, ex-
pressed both B220 (CD45R) and c-kit (CD117) on the cell
surface (Fig. 2 B, and data not shown). Thus, pre-BI cells
from the VpreB1/VpreB2 double-deficient mice lacked sur-
face VpreB expression.
As l5 is also part of the pro-BCR and was expressed as
RNA in VpreB12/2VpreB22/2 bone marrow cells, we ana-
lyzed the in vitro–cultured cells for the presence of this pro-
tein using the mAb LM34 (13). Pre-BI cells from heterozy-
gous mice expressed l5 on the cell surface. In contrast, the
cells from VpreB12/2VpreB22/2 mice were not recognized
by the LM34 Ab and thus did not express l5 on the cell
surface (Fig. 2 B). Analysis of cells from ES163 mice dem-
onstrated that both VpreB and l5 could be detected on the
surface of pre-BI cells derived from wild-type and het-
erozygous but not homozygous VpreB1/VpreB2 double-
mutant mice (data not shown). Thus, the targeting of the
two VpreB genes resulted in a lack of VpreB protein on the
surface of pre-BI cells. In addition, although expressed as
RNA, l5 protein was also not detected on the cell surface.
B Cell Development Is Impaired in VpreB12/2VpreB22/2
Mice at the Transition from Pre-BI to Pre-BII Cells. After
confirming that the targeting of both VpreB genes on the
same chromosome resulted in a lack of VpreB RNA and
protein expression we analyzed whether this had an effect
on B cell development. We observed no differences be-
tween wild-type and heterozygous VpreB1/VpreB2 dou-
ble-mutant mice (data not shown). The data from these
mice were therefore pooled and represent control mice.
The number of cells in different bone marrow cell popu-
lations of control mice varied between two- and sevenfold
depending on age. Therefore, the mice were separated into
two age groups. Table I summarizes the data from mice
aged 10 and 50–70 d, respectively. As shown in Table I,
the lack of both VpreB1 and VpreB2 caused a slight decrease
in total number of nucleated bone marrow cells in young
mice. This difference became more apparent in older mice
(z60% of control). Furthermore, the numbers of B2201
cells in young and old VpreB12/2VpreB22/2 mice were also
lower, around half that of control mice. The number of
CD191 lymphocytes was similarly decreased (Table I). It
has been shown by Rolink et al. that most of the
B2201CD192 cells in bone marrow not only include pro-B
cells but also progenitors of other cell types, e.g., NK cells
(36). However, the total number of B2201CD192 cells in
VpreB12/2VpreB22/2 mice was similar to that in control
mice. Hence, it appears that the lack of both VpreB1 and
VpreB2 has either no or very little effect on this cell popu-
lation.
To determine at which point of development the defect
in both VpreB genes impedes B-lineage cell generation the
sizes of cellular pools of pre-BI, large and small pre-BII, and
immature and mature B cells in bone marrow were deter-
mined by FACS® analysis using B220, CD19, c-kit, CD25,
and cell size as distinguishable markers (Fig. 3 A and Table
I). VpreB1/VpreB2 double-deficient mice showed an about
twofold increase in the number of B2201c-kit1 pre-BI cells
compared with control mice. The number of CD191c-kit1
cells was also increased about twofold (data not shown). By
contrast, the number of B2201CD251 pre-BII cells was se-
verely reduced. In young mice, the difference in cell num-
bers, compared with control littermates, was z40-fold,
whereas it was z10-fold in older mice. These results suggest
that the lack of VpreB1 and VpreB2 expression result in a de-
fect in the generation of pre-BII from pre-BI cells, i.e., at
the stage of surface pre-BCR expression.
Lack of Proliferative Expansion at the Pre-BII Cell Stage.
Pre-BII cells (B2201CD251) can be divided into large cy-
cling and small resting cells (2). We determined the ratio
between these subsequent stages of B cell development in
VpreB1/VpreB2 double-deficient old mice. The number of
B2201CD251 cells in young VpreB12/2VpreB22/2 mice
was too low to give meaningful results (Fig. 3 A; ,1%). In
control mice, the ratio of large versus small pre-BII cells
was 1:4, whereas in VpreB1/VpreB2 double-mutant mice
the ratio was 1:1–1.5. Thus, in VpreB1/VpreB2 double-
deficient mice there was an z5-fold reduction in large and
an z15-fold reduction in small pre-BII cells. Hence, the
lack of both VpreB1 and VpreB2 proteins affected the pro-
duction of both large and small pre-BII cells, with the
greatest impact on small pre-BII cells. It suggests that, as in
l52/2 mice, the proliferative expansion of pre-BII cells
does not occur and/or that the progression from large to
small cells is impaired.
Reduced Numbers of Immature and Mature B Cells in Bone
Marrow of VpreB1/VpreB2 Double-mutant Mice. In VpreB12/2
VpreB22/2 mice, the total numbers of sIgM1 immature and
mature B cells were severely reduced, z25-fold in young
and 10-fold in old mice. Comparable reductions in num-
Table I. Impaired B Cell Development in
VpreB12/2VpreB22/2 Mice
Bone marrow
population Days* N‡
Control
(mean 6 SEM) N‡
Homozygous
(mean 6 SEM)
Total 10 3 14.60 6 3.54 3 11.83 6 0.44
50–70 6 33.92 6 3.19 6 20.70 6 4.32
B2201 10 3 2.97 6 0.88 3 1.57 6 0.13
50–70 6 10.63 6 1.03 6 3.95 6 0.80
CD191 10 3 2.84 6 0.88 3 1.38 6 0.10
50–70 6 9.98 6 1.10 6 3.07 6 0.79
B2201c-kit1 10 3 0.40 6 0.13 3 1.01 6 0.11
50–70 6 0.94 6 0.30 6 1.71 6 0.41
B2201CD251 10 3 1.24 6 0.29 3 0.03 6 0.003
50–70 6 6.33 6 0.81 6 0.64 6 0.20
B2201IgM1 10 3 0.48 6 0.10 3 0.02 6 0.01
50–70 6 3.43 6 0.36 5 0.40 6 0.15
The mean and SEM of absolute numbers (3 106) are shown for the
indicated cell populations in the bone marrow of control and
homozygous VpreB1/VpreB2 double-mutant mice.
*Age of mice.
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bers of sIgM1kL1 B cells were observed (data not shown).
As shown in Fig. 3 A, sIgM1sIgD1 mature B cells in bone
marrow were reduced as much as the sIgM1 immature B
cells.
As small pre-BII cells are the precursors of immature B
cells, we analyzed the sizes of these two populations. Inde-
pendent of genotype, the proportion of immature B cells
was z50% of the sIgM1 population. In control mice,
z5 3 106 small pre-BII cells and z1.5 3 106 immature B
cells were found, whereas in the VpreB1/VpreB2 double-
mutant mice these values were z0.4 3 106 and z0.2 3
106, respectively. From these data it appears likely that the
VpreB1/VpreB2 double defect does not significantly affect
the transition from small pre-BII to immature B cells in the
bone marrow.
In conclusion, in the absence of VpreB1 and VpreB2
protein, bone marrow was enriched in pre-BI cells, de-
creased in large, and decreased even more in small pre-BII
cells, whereas the differentiation of the latter population
into immature B cells was unaffected. These data suggest a
defect at the transition from pre-BI to large pre-BII cells,
due to either a lack of proliferative expansion at, or an im-
pairment of the progression through the pre-BII stage, re-
sulting in the production of much lower numbers of pre-
BII and immature B cells.
Decreased Numbers of B Cells in the Spleen of VpreB12/2
VpreB22/2 Mice. Bone marrow is a primary lymphoid
organ which generates B lymphocytes that migrate as im-
mature B cells into the spleen where they mature. There-
fore, we analyzed the effect of the VpreB1/VpreB2 double
mutation on the generation of splenic B cells. Data shown
in Fig. 3 B and Table II demonstrate that the lack of both
VpreB1 and VpreB2 caused a strong reduction in the num-
ber of B2201CD191 B cells. The number of cells defined
as either B2201 or CD191 cells decreased z10-fold in
young and z5-fold in older mutant mice. Total nucleated
cells were z70% of normal in young and z45% in older
mice.
Only half of the B2201 cells were also sIgM1 in double-
mutant mice, whereas 80–90% were sIgM1 in control lit-
termates. In the sIgM1 B cell pool, an z15- and 5-fold re-
duction was seen in VpreB12/2VpreB22/2 young versus
old mice, respectively. Further determinations of the
numbers of sIgD-expressing cells showed that 60–70% of
the sIgM1 cells were also IgD1 in young double-mutant
mice, compared with z90% in control littermates. How-
ever, in old double-mutant mice this percentage had
reached normal levels (90–100%). In actual cell numbers,
z5-fold fewer immature (sIgM1sIgD2) and z20-fold
fewer mature (sIgM1sIgD1) B cells were found in young,
and z5-fold fewer mature B cells in old double-mutant
mice. Thus, with age, the number of B cells increased in
VpreB12/2VpreB22/2 mice, and most of these cells were
of a mature phenotype.
Furthermore, the ratio of Ig kL versus lL chain expres-
sion in splenic B cells was found to be similar (15:1 versus
30:1) as determined in old control and double-mutant
mice, respectively. This suggests that the lack of VpreB1
Figure 3. Impaired B cell development in VpreB12/2
VpreB22/2 mice. (A) FACS® analysis of bone marrow cells
from VpreB11/2VpreB21/2 (top) and VpreB12/2VpreB22/2
(bottom) ES94-derived 10-d-old littermates. Cells were
stained for B220 (CD45R) in combination with either
CD19, c-kit (CD117), CD25, IgM, or IgD. Cells falling
within the lymphocyte gate are displayed. Numbers indicate
percentage of cells within this quadrant. (B) FACS® analysis
of spleen cells from the mice in A. Cells were stained for
B220 in combination with CD19, IgM, IgD, or Igl, and
also with IgM in combination with IgD. Cells falling within
the lymphocyte gate are displayed. Numbers indicate per-
centage of cells within this quadrant. (C) FACS® analysis of
peritoneal cells from VpreB11/1VpreB21/1 and VpreB12/2VpreB22/2 ES94 mice stained for B220 and CD5 aged 12 d and 12 wk, respectively. Cells fall-
ing within the lymphocyte gate are displayed. The numbers indicate the percentage of cells within these regions.441 Mundt et al.
and VpreB2 expression did not affect the rearrangements at
the IgL chain gene loci, and the repertoire selection of kL1
versus lL1 sIgM1 B cells. Comparable results were ob-
tained with the second strain of VpreB12/2VpreB22/2 mice
(ES163, data not shown). In addition, no alterations were
found in the numbers of thymocytes or in CD41 and
CD81 T cells in the periphery of double-mutant mice (data
not shown).
In conclusion, in the absence of VpreB1 and VpreB2, the
number of B-lineage cells in the spleen of young mice was
greatly decreased with a large proportion of these cells ex-
pressing an immature phenotype. However, in older mice,
most of the B cells showed a mature phenotype although
their numbers had not fully recovered at 70 d of age.
Impaired Development of B-1a Cells in the Peritoneum of
VpreB12/2VpreB22/2 Mice. Although a large proportion
of splenic B cells are expected to belong to the conven-
tional B cell compartment, B cells in the peritoneum ap-
pear enriched for B-1 type B cells (37). B-1a cells are char-
acterized as B2201CD51sIgMhighsIgDdull. Fig. 3 C and
Table III show that the number of B-1a cells was reduced
eightfold in young (10–12-d-old) mice, whereas at 9–13
wk of age the B-1a compartment in the peritoneum of
double-mutant mice had reached the size of that in wild-
type littermates. Heterozygous VpreB1/VpreB2 mice were
comparable in their B-1a development to wild-type mice.
The B2201CD51 B-1a cells of double-mutant mice were
also analyzed for other markers, such as sIgMhigh and sIgDdull,
and were found to be normal (data not shown).
The analyses of peritoneal cells also demonstrated that the
percentages and absolute numbers of other B-lineage cells,
i.e., of B2201CD52 cells were reduced z15-fold in 10–12-
d-old VpreB1/VpreB2 double-mutant mice (Fig. 3 C and
Table III). Independent of genotype, almost all these cells
were IgM1 with varying IgD levels, demonstrating that
they were B-lineage cells. In contrast to the B2201CD51
B-1a cells, the B2201CD52 B cells had not reached normal
levels by 9–13 wk of age. In contrast, both to B-1a and
B2201CD52 cells, the B2202CD51 non–B-lineage com-
partment was normal both in young and old double-mutant
mice (Fig. 3 C and Table III). We conclude that the gener-
ation of the B-1a cell pool in peritoneum is initially affected
by the lack of VpreB1 and VpreB2. With age this pool fills
to normal size even in VpreB12/2VpreB22/2 mice. How-
ever, as with B cells in spleen of double-mutant mice, the
remaining peritoneal B cell populations, which would be
either B-1b or conventional B cells, have not yet fully re-
covered at 70 d of age.
Normal Levels of IgM in Serum. Sera from 5-mo-old
VpreB1/VpreB2 double-mutant mice were analyzed by
ELISA for the amounts of IgM and found to be z0.8–1
mg/ml in VpreB12/2VpreB22/2 mice, compared with
z0.8–0.9 mg/ml in wild-type and heterozygous litter-
mates. Thus, serum IgM levels appeared not to be nega-
tively affected by the lack of VpreB1 and VpreB2.
T Cell–dependent and –Independent Immune Responses.
To investigate whether B cells in VpreB12/2VpreB22/2
mice were able to mount an immune response, we immu-
nized mice 4–5 mo of age with T cell–dependent antigens
(oxazolone coupled to OVA or OVA without hapten) as
well as with a T cell–independent antigen (NP-Ficoll). Af-
ter 2 wk, the mice were bled and the antigen-specific Ab
responses analyzed. The results in Fig. 4 demonstrate that
VpreB12/2VpreB22/2 mice were able to respond to both
types of antigens. In terms of IgM and IgG responses
against NP-Ficoll, VpreB12/2VpreB22/2 mice mounted an
as good immune response as wild-type and heterozygous
control mice (Fig. 4, and data not shown). In the case
of T cell–dependent antigens, VpreB12/2VpreB22/2 mice
showed slightly lowered antigen-specific IgG responses
Table II. Decreased Numbers of B Cells in the Spleen of 
VpreB12/2VpreB22/2 Mice
Population Days* N‡
Control
(mean 6 SEM) N‡
Homozygous
(mean 6 SEM)
Total 10 3 45.50 6 9.57 3 30.67 6 4.06
50–70 6 136.17 6 10.80 6 59.33 6 10.45
B2201 10 3 9.63 6 2.38 3 1.10 6 0
50–70 6 44.83 6 3.53 6 9.88 6 1.77
CD191 10 3 9.20 6 2.60 3 0.99 6 0.07
50–70 6 43.80 6 3.65 6 8.90 6 1.45
B2201IgM1 10 3 8.48 6 2.18 3 0.58 6 0.06
50–70 6 36.97 6 3.15 6 8.58 6 1.33
B2201IgD1 10 3 7.49 6 2.02 3 0.39 6 0.09
50–70 6 39.82 6 2.98 6 7.96 6 0.90
The mean and SEM of absolute numbers (3 106) are shown for the
indicated cell populations in the spleen of control and homozygous
VpreB1/VpreB2 double-mutant mice.
*Age of mice.
‡Number of mice analyzed.
Table III. Reduction in B-1a B Cells in
VpreB12/2VpreB22/2 Mice
Age Genotype N* B-1a B2201CD52 B2202CD51
10–12 d 1/1 3 0.31 6 0.04 0.17 6 0.03 0.04 6 0.01
1/2 5 0.24 6 0.10 0.14 6 0.07 0.03 6 0.01
2/2 3 0.04 6 0.01 0.01 6 0 0.03 6 0.01
16 d 1/1 2 0.58 6 0.01 0.64 6 0.05 0.08 6 0.01
1/2 6 0.80 6 0.01 0.77 6 0.12 0.14 6 0.02
2/2 2 0.15 6 0.04 0.08 6 0.01 0.13 6 0.01
9–13 wk 1/1 5 31.25 6 6.57 49.03 6 7.90 29.42 6 7.03
1/2 6 33.05 6 8.75 47.65 6 9.01 29.51 6 6.89
2/2 8 21.22 6 3.38 13.01 6 1.73 31.08 6 6.24
The mean 6 SEM of absolute numbers (104) are shown for B-1a
(B2201CD51), B2201CD52 and B2202CD51 lymphocyte populations
in the peritoneum of mice of indicated VpreB1/VpreB2 genotype
and age.
*Number of mice.442 Impaired B Cell Development in VpreB12/2VpreB22/2 Mice
compared with control mice (Fig. 4). Thus, the emerging
B cells in VpreB12/2VpreB22/2 mice are functional in
terms of immune responses.
Allelic Exclusion in Immature B Cells. It has been pro-
posed that the pre-BCR signals allelic exclusion of the IgH
chain. As l52/2 mice still display allelic exclusion, it has
been hypothesized that VpreB alone, in the absence of l5,
can pair with mH chain and cause IgH allelic exclusion (25).
This would imply that the lack of VpreB1 and VpreB2
would cause IgH allelic inclusion. We have shown previ-
ously that the single VpreB1 deficiency does not abolish al-
lelic exclusion (32). Hence, VpreB2 could still function as a
component of a pre-BCR signaling allelic exclusion. This
should no longer be possible in VpreB12/2VpreB22/2 mice.
To test this, IgMa/IgMb heterozygous bone marrow cells
from VpreB1/VpreB2 double mutant and control ES94 mice
were analyzed for expression of IgMa and IgMb allotypes on
single B cells by FACS®. Upon allelic inclusion, the calcu-
lated theoretical value of double producers (IgMaIgMb)
would be 12% (30). Due to the very low number of imma-
ture B cells (B2201IgM1IgD2) in the bone marrow of dou-
ble-mutant mice, all cells from both femurs were collected
and analyzed. As shown in Fig. 5, in wild-type mice, z55%
of the IgM1 cells expressed only IgMa and 44% only IgMb
on their surface, whereas 1.2% of the cells stained positive
for both markers. In the VpreB12/2VpreB22/2 mice, the
percentages of cells expressing either IgMa or IgMb only
were very similar to that of control mice. Most importantly,
the percentage of cells expressing both IgMa and IgMb was
only 2%. This demonstrates that in the absence of VpreB1
and VpreB2, immature B cells in the bone marrow were still
allelically excluded at the IgH locus.
Discussion
The production and surface deposition of the pre-BCR
on pre-BII cells has been shown to signal these cells to
enter two to five rounds of cell division, expanding the in-
dividual mH chain repertoire within the developing B-lin-
eage cells between 2- and 30-fold (26). Whenever the pre-
BCR cannot be deposited on the surface, be it that the
DJH/DJH-rearranged pre-BI cell has not entered an in-
frame VH to DJH rearrangement preventing the expression
of a mH chain, that the mH chain made from a productive
rearrangement cannot pair with SL chain (25), that the mH
chain cannot be deposited in the surface membrane be-
cause of a lack of its transmembrane portion (30), that no
Ig rearrangement can occur in pre-BI cells as is the case in
SCID and RAG-deficient mice (38-40), or that produc-
tion of the l5-component of the pre-BCR is defective as
in l52/2 mice (17, 31), then this proliferation of pre-BII
cells does not occur either in vivo or in vitro (26, 41). The
analyses of the precursor B cell compartments in the bone
marrow of VpreB12/2VpreB22/2 mice presented here al-
low us now to add one more important deficiency of the
pre-BCR to this list, which abolishes the proliferative ex-
pansion of precursor B cells at the transition from pre-BI to
pre-BII cells. Although we have shown previously that the
single deficiency of one of the VpreB genes of the mouse,
i.e., the VpreB1 gene, does not impede in a major way this
proliferative expansion of pre-BII cells (32), the double de-
ficiency of both known VpreB genes does. This result then
establishes that proliferative expansion of large pre-BII cells
is controlled by surface deposition of a pre-BCR com-
posed of mH chain, l5-protein, and either VpreB1 or
VpreB2 protein, and that no other VpreB-like protein can
assume the role of the two VpreB proteins for this cellular
function. Hence, VpreB3, the protein encoded by 8HS20,
also expressed in early B cell development, does not re-
place VpreB1 and VpreB2 in this signaling function (42).
VpreB12/2VpreB22/2 B-lineage cells show strikingly
similar impairment in B cell development to l5-defective
Figure 4. T cell–dependent and –indepen-
dent immune responses. 4 to 5-mo-old mice
of the indicated genotypes, were immunized
with either NP-Ficoll or alum-precipitates of
either oxazolone-ovalbumin (Ox) or ovalbu-
min (Ov). 2 wk later, the mice were bled and
the sera analyzed in ELISA. The data are rep-
resented as titers. Preimmune sera were ,1.
wt, wild-type; het, heterozygous; homo, ho-
mozygous.
Figure 5. Allelic exclusion of Ig mH chain expression on IgMaIgMb F1
B cells. FACS® analysis of bone marrow cells from ES94-derived VpreB1/
VpreB2 double-mutant littermates of the indicated genotype at the age of
74 d. All cells from both femurs were stained for B220 in combination
with IgD, IgMa, and IgMb. Cells falling both within the lymphocyte and
the B2201IgD2 gate were analyzed for expression of IgMa and IgMb. The
numbers indicate the percentage of cells within these regions. Only 10%
of the gated cells are shown for wild-type.443 Mundt et al.
cells (17, 31). Because proliferative expansion of pre-BII
cells is abolished, the generation of B-lineage cells from
DJH/DJH-rearranged pre-BI cells becomes less efficient
(31). For l52/2 pre-BI cells it has been shown that the ki-
netics and rates of formation of sIgM1 and sIg2 B cells is
indistinguishable from wild-type pre-BI cells. This argues
that it is not efficiency of progression in differentiation
through the pre-BI to pre-BII to immature B cell stages,
but rather the lack of proliferation of l52/2 pre-BII cells
that accounts for the overall B cell developmental defect
(31). Thus, in vitro studies of the kinetics and rates of dif-
ferentiation have yet to be done with VpreB12/2VpreB22/2
pre-BI cells, in order to further investigate the similarity or
possible difference in the differentiation capacities of wild-
type, l52/2, and VpreB12/2VpreB22/2 pre-BI cells.
Beyond the pre-BII stage of B cell development, no ma-
jor effect was observed in VpreB12/2VpreB22/2 mice, a sit-
uation very similar to that in l52/2 mice. This is illustrated
by the B-1a cell compartment and the IgM levels in serum,
which become normalized soon after birth, resembling
those of wild-type mice, whereas the defect in the accumu-
lation and proper filling of the conventional B cell compart-
ment remains visible for several months after birth. Also, the
decreased cellularity of the peripheral, conventional B cell
compartment does not impede T cell–independent or T
cell–dependent responses of the VpreB12/2VpreB22/2 mice.
Major changes in VH-repertoires of mH chain originally
expressed in VH to DJH-rearranging precursor B cells are
observed in wild-type mice as the pre-BCRs form (18). In
fact, approximately half of all originally generated mH
chains cannot pair with SL chain to form and deposit a pre-
BCR on the cell surface. Hence, these are excluded from
the proliferative expansion of large pre-BII cells and conse-
quently are infrequent or absent in the repertoire of small
pre-BII, immature, and mature B cells. In l52/2 mice, IgL
chains appear to take the functional role of SL chain.
Therefore, a very similar change in the VH repertoire of
mH chains produced occurs in l52/2 mice at the transition
of precursor B into immature B cells (18). It remains to be
investigated whether a similar change in the VH repertoire
of mH chains can also be observed in VpreB12/2VpreB22/2
mice which, again, would possibly be mediated by IgL
chains.
It has been proposed that surface deposition of pre-BCRs
on precursor B cells, at the transition from pre-BI to pre-
BII cells, also signal the cells to allelically exclude the VH to
DJH rearrangement at the DJH-rearranged second IgH chain
allele. This, in fact should be the case in half of all develop-
ing B-lineage cells in which the second allele remains DJH
rearranged (5). The signal should cause a rapid downregula-
tion of the expression of the rearrangement machinery, i.e.,
RAG-1,  RAG-2, and TdT transcripts and proteins. It
should also signal a closure of the DJH-rearranged IgH chain
allele for further VH to DJH rearrangements, especially in
cells at later stages of development, i.e., in small pre-BII
cells which reactivate the recombination machinery and VL
to JL rearrange the kL and lL chain gene loci (20).
It was already surprising that l5-deficient mice still
showed allelically excluded B cell compartments (25). To
explain allelic exclusion in l52/2 mice, it was proposed
that a modified pre-BCR consisting of mH chain and
VpreB protein might act as signaling receptor (25). In line
with this suggestion, it was observed that mH chains could
bind to VpreB1 and VpreB2 proteins in the absence of l5
protein, and that SL chain pairing mH chains could do so,
whereas nonpairing mH chains could not (unpublished ob-
servations). In VpreB12/2VpreB22/2 precursor B cells, such
modified pre-BCRs should not be made. Further, it has
been shown that l5 alone cannot form a l5-mH chain
modified pre-BCR, as in the absence of VpreB protein, l5
appears not to bind to a whole series of SL chain pairing as
well as nonpairing mH chains (unpublished observations).
All the more surprising, therefore, is our present finding
that allelic exclusion of the mH chain does still function in
the double-defective VpreB12/2VpreB22/2 mice.
How, then, can allelic exclusion happen? It appears from
studies with mH chain transmembrane region–deficient
mice (30) and from studies of double mH chain–producing
B cells of wild-type mice, in which only one mH chain can
pair with SL chain, that membrane insertion of the mH
chain is required for allelic exclusion. In the absence of
both  VpreB1 and VpreB2, two other candidates could possi-
bly be part of a modified pre-BCR. One is the chaperone
BiP, which is known to associate with mH chains before SL
chain association (43). The other is the 8HS20-encoded
VpreB3 protein (42). We will have to combine defects in
these genes with the VpreB1, VpreB2, and l5 defects to in-
vestigate these possible pre-BCR–like associations and their
roles in allelic exclusion. This is experimentally compli-
cated, as VpreB1, VpreB2, l5, and VpreB3 all appear located
on the same chromosome (44).
Yet another scenario for allelic exclusion at the mH
chain loci is suggested from the finding that in l52/2 mice
IgL chains take the place of SL chain to change the reper-
toire of VH-representation during B cell development. In
the absence of proliferative expansion of pre-BII cells in
these l52/2 mice, differentiation from pre-BI to small pre-
BII cells might occur much more rapidly than in wild-type
mice, so that VL to JL rearrangements might occur immedi-
ately following VH to DJH-rearrangements, so that a BCR
could signal the cell to turn off the recombination machin-
ery and close the IgH chain loci. In line with such func-
tional roles of IgL chains in precursor B cells, it has been
observed that the abnormally early expression of transgenic
IgL can repair the l5 defect in B cell development,
whereas in the absence of both l5 and IgL there is a com-
plete block in B-lymphocyte production (45, 46). Early ex-
pression of L chain would also predict that signaling by the
pre-BCR of proliferative expansion of large pre-BII cells
would, in fact, also signal inhibition of IgL chain gene ex-
pression in these wild-type cells. If such a scenario were
correct, we would predict that a VpreB1-, VpreB2-,
VpreB3-, and l5-deficient mouse would still show allelic
exclusion at the IgH chain loci.444 Impaired B Cell Development in VpreB12/2VpreB22/2 Mice
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